Mark A. Kronenfeld, Director at Pacira BioSciences, Inc. (PCRX), sold 15,000 shares at $37.04 ($556K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Scheduled sale ($556k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PCRX | BUY | 2017-11-13 | $42K | — | Filing → |
| PCRX | SELL | 2016-06-08 | $42K | — | Filing → |
| PCRX | BUY | 2014-11-04 | $77K | — | Filing → |